Why the study?
Does labetalol compared to sodium nitroprusside safely and effectively control hypertension in patients post-coronary bypass surgery?
Does labetalol compared to sodium nitroprusside safely and effectively control hypertension in patients post-coronary bypass surgery?
Labetalol is a safe and effective alternative to sodium nitroprusside for controlling postoperative hypertension following coronary artery bypass surgery, with differing hemodynamic mechanisms and a reduction in subsequent vasodilator requirements.
No takes yet. Share an insight, caveat, or question.
Labetalol offers a hemodynamically distinct alternative to SNP for post-CABG hypertension; extends perioperative options by reducing subsequent vasodilator needs.
Cruise et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: